NovaBridge Biosciences
NBP · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$50 | -$208 | -$2,507 | -$2,332 |
| Dep. & Amort. | $1 | $1 | $64 | $34 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | -$2 | $10 | $357 | $609 |
| Change in WC | -$3 | -$37 | $552 | $395 |
| Other Non-Cash | $1 | $161 | $431 | $321 |
| Operating Cash Flow | -$53 | -$73 | -$1,103 | -$973 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$46 | -$30 |
| Net Acquisitions | $0 | $0 | $0 | -$6 |
| Inv. Purchases | -$246 | $0 | -$7,407 | -$10,173 |
| Inv. Sales/Matur. | $110 | $0 | $7,912 | $9,482 |
| Other Inv. Act. | $0 | -$107 | $0 | $0 |
| Investing Cash Flow | -$136 | -$108 | $458 | -$727 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $3 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$0 | -$9 | -$3 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $43 | $594 |
| Financing Cash Flow | -$0 | -$8 | $42 | $594 |
| Forex Effect | -$45 | $37 | $389 | -$129 |
| Net Chg. in Cash | -$234 | -$152 | -$213 | -$1,235 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $302 | $463 | $3,524 | $4,759 |
| End Cash | $68 | $311 | $3,311 | $3,524 |
| Free Cash Flow | -$53 | -$73 | -$1,149 | -$1,003 |